Health Secretary Plans to Announce Potential Link Between Tylenol Use During Pregnancy and Autism
Health Secretary Robert F. Kennedy Jr. is expected to announce a potential link between Tylenol use during pregnancy and autism, a claim that has been met with skepticism from medical experts and the pharmaceutical industry.
Health Secretary Robert F. Kennedy Jr. is reportedly preparing to announce findings that suggest a potential link between the use of Tylenol (acetaminophen) during pregnancy and an increased risk of autism in children. This anticipated announcement has sparked debate among medical professionals and the pharmaceutical industry.
The Department of Health and Human Services (HHS) has cautioned that any claims about the forthcoming report are speculative until its official release. A spokesperson for HHS stated, "We are using gold-standard science to get to the bottom of America's unprecedented rise in autism rates. Until we release the final report, any claims about its contents are nothing more than speculation."
Kenvue, the manufacturer of Tylenol, defended the safety of its product, emphasizing that leading medical organizations and the U.S. Food and Drug Administration (FDA) consider acetaminophen safe for use during pregnancy. The company advised pregnant women to consult with healthcare professionals before using the medication.
Medical experts have expressed skepticism regarding the alleged link between acetaminophen use during pregnancy and autism. The American College of Obstetricians and Gynecologists (ACOG) stated, "There is no clear evidence that proves a direct relationship between the prudent use of acetaminophen during pregnancy and fetal developmental issues."
Recent studies have yielded mixed results. A 2024 study involving 2.5 million Swedish children found no causal link between prenatal acetaminophen exposure and autism. Conversely, a 2025 review of 46 prior studies suggested a possible association but did not establish causation. Researchers emphasize the importance of using acetaminophen minimally and under medical guidance during pregnancy.
The forthcoming report from HHS is expected to further investigate these claims and provide more clarity on the potential risks associated with acetaminophen use during pregnancy.